Identification of new lead molecules against anticancer drug target TFIIH subunit P8 using biophysical and molecular docking studies.
The identification of molecules, which could modulate protein-protein interactions (PPIs), is of primary interest to medicinal chemists. Using biophysical methods during the current study, we have screened 76 compounds (grouped into 16 mixtures) against the p8 subunit of the general transcription factor (TFIIH), which has recently been validated as an anti-cancer drug target. 10% of the tested compounds showed interactions with p8 protein in STD-NMR experiments. These results were further validated by molecular docking studies where interactions between compounds and important amino acid residues were identified, including Lys20 in the hydrophobic core of p8, and Asp42 and 43 in the β3 strand. Moreover, these compounds were able to destabilize the p8 protein by negatively shifting the Tm (≥2 °C) in thermal shift assay. Thus, this study has identified 8 compounds which are likely negative modulators of p8 protein stability, and could be further considered as potential anticancer agents.
['Javaid|Sumaira|S|', 'Zafar|Humaira|H|', 'Atia-Tul-Wahab|||', 'Gervais|Virginie|V|', 'Ramos|Pascal|P|', 'Muller|Isabelle|I|', 'Milon|Alain|A|', 'Atta-Ur-Rahman|||', 'Choudhary|M Iqbal|MI|']
p8 subunit DNA transcription, anti-cancer agents, STD-NMR Differential scanning fluorimetry Nucleotide excision repair (NER)